APAAACI 2024 International Congress
Dec 12 - Dec 15, 2024
- Title: RAPIDe-2 Study: Long-term Efficacy and Safety of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks
Presenter: Markus Magerl, M.D.
Format: Oral Presentation 2
Date, time: Friday, December 13, 2024, 2:20-2:30 p.m. MYT (1:20-1:30 a.m. EST) - Title: Prophylaxis of Hereditary Angioedema Attacks With Oral Deucrictibant: Efficacy and Quality-of-Life Results from CHAPTER-1
Presenter: Markus Magerl, M.D.
Format: Oral Presentation 4
Date, time: Saturday, December 14, 2024, 2:00-2:10 p.m. MYT (1:00-1:10 a.m. EST) - Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Hereditary Angioedema Prophylaxis: The CHAPTER-1 Open-Label Extension Study
Presenter: Markus Magerl, M.D.
Format: Oral Presentation 1
Date, time: Sunday, December 15, 2024, 3:20-3:30 p.m. MYT (2:20-2:30 a.m. EST) - Title: RAPIDe-3 Phase 3 Trial Design: Oral Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks
Presenter: Phillip H. Li, MBBS, FRCP
Format: Poster 012
Date, time: Sunday, December 15, 2024 - Title: Propensity Score-Matched Comparison of Outcomes for Deucrictibant vs Standard of Care in People Living with Hereditary Angioedema
Presenter: Phillip H. Li, MBBS, FRCP
Format: Poster 018
Date, time: Sunday, December 15, 2024